The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

David V. Gold

Center for Molecular Medicine and Immunology

Garden State Cancer Center

Morris Plains

NJ 07950



Name/email consistency: high



  • Center for Molecular Medicine and Immunology, Garden State Cancer Center, Morris Plains, NJ 07950, USA. 2004 - 2013
  • Garden State Cancer Center, Belleville, New Jersey 07109, USA. 2003


  1. PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinoma. Gold, D.V., Gaedcke, J., Ghadimi, B.M., Goggins, M., Hruban, R.H., Liu, M., Newsome, G., Goldenberg, D.M. Cancer (2013) [Pubmed]
  2. Detection of early-stage pancreatic adenocarcinoma. Gold, D.V., Goggins, M., Modrak, D.E., Newsome, G., Liu, M., Shi, C., Hruban, R.H., Goldenberg, D.M. Cancer Epidemiol. Biomarkers Prev. (2010) [Pubmed]
  3. Enhanced expression of CD74 in gastrointestinal cancers and benign tissues. Gold, D.V., Stein, R., Burton, J., Goldenberg, D.M. Int. J. Clin. Exp. Pathol (2010) [Pubmed]
  4. A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma. Gold, D.V., Goldenberg, D.M., Karacay, H., Rossi, E.A., Chang, C.H., Cardillo, T.M., McBride, W.J., Sharkey, R.M. Cancer Res. (2008) [Pubmed]
  5. PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma. Gold, D.V., Karanjawala, Z., Modrak, D.E., Goldenberg, D.M., Hruban, R.H. Clin. Cancer Res. (2007) [Pubmed]
  6. New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis. Gold, D.V., Modrak, D.E., Ying, Z., Cardillo, T.M., Sharkey, R.M., Goldenberg, D.M. J. Clin. Oncol. (2006) [Pubmed]
  7. Combined 90Yttrium-DOTA-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograft. Gold, D.V., Modrak, D.E., Schutsky, K., Cardillo, T.M. Int. J. Cancer (2004) [Pubmed]
  8. Low-dose radioimmunotherapy ((90)Y-PAM4) combined with gemcitabine for the treatment of experimental pancreatic cancer. Gold, D.V., Schutsky, K., Modrak, D., Cardillo, T.M. Clin. Cancer Res. (2003) [Pubmed]
WikiGenes - Universities